SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001040197-24-000005
Filing Date
2024-07-10
Accepted
2024-07-10 16:16:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4320
  Complete submission text file 0001040197-24-000005.txt   6291
Mailing Address 6050 OAK TREE BLVD SUITE 500 INDEPENDENCE OH 44131
Business Address 6050 OAK TREE BLVD SUITE 500 INDEPENDENCE OH 44131 216-436-3500
MAI Capital Management (Filed by) CIK: 0001040197 (see all company filings)

IRS No.: 611495162 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Subject) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91005 | Film No.: 241110144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)